Table 1 Demographic description and features related to PDR among HIV-1 newly diagnosed in Angola.

From: HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-naïve adult patients in Luanda, Angola

Independent variable

N (%)

Any PDR to PR/RT/IN§

No (%)

Yes (%)

p-value#

Overall

48 (100)

35 (77.8)

10 (22.2)

 

Age (year)—mean ± SD

34.4 ± 8.84

35.3 ± 8.39

32.6 ± 10.2

0.394

Age distribution

 ≤ 30 years

21 (43.8)

13 (68.4)

6 (31.6)

0.281

 > 30 years

27 (56.3)

22 (84.6)

4 (15.4)

 

Sex

 Female

6 (12.5)

4 (80.0)

1 (20.0)

0.899

 Male

42 (87.5)

31 (77.5)

9 (22.5)

 

Residence area

 Non-urbanized

25 (52.1)

18 (78.3)

5 (21.7)

0.936

 Urbanized

23 (47.9)

17 (77.3)

5 (22.7)

 

Occupation

 Unemployed

9 (18.8)

5 (62.5)

3 (37.5)

0.349

 Employed

39 (81.3)

30 (81.1)

7 (18.9)

 

HIV-1 subtypes

 C

16 (33.3)

11 (68.8)

5 (31.3)

0.460

 F1

8 (16.7)

4 (57.1)

3 (42.9)

 

 G

7 (14.6)

5 (100)

0 (0.0)

 

 A1

5 (10.4)

5 (100)

0 (0.0)

 

 H

3 (6.30)

2 (66.7)

1 (33.3)

 

 D

2 (4.20)

2 (100)

0 (0.0)

 

 CRF02_AG

2 (4.20)

2 (100)

0 (0.0)

 

 Other HIV-1 strains

5 (10.4)

5 (100)

0 (0.0)

 
  1. #Chi-square (X2) test or Fisher's exact test.
  2. §Three samples did not amplify for the three PR/RT/IN fragments, simultaneously.
Back to article page